Incyte Reports 2015 Third-Quarter Financial Results and Updates Shareholders on Key Clinical Programs
Go back to Incyte Reports 2015 Third-Quarter Financial Results and Updates Shareholders on Key Clinical Programs| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 124.38 -2.37 (1.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $126.75 | 52 Week High | $118.49 | |||
| Open | $124.11 | 52 Week Low | $55.00 | |||
| Day High | $125.70 | P/E | N/A | |||
| Day Low | $122.22 | EPS | $-0.56 | |||
| Volume | 241,217 | |||||
